McKenna SP, Whalley D, Doward LC. Improving the measurement properties of the quality of life in depression scale. Poster presented at the 2002 ISPOR 5th Annual European Congress; November 2002. Rotterdam, The Netherlands. [abstract] Value Health. 2002 Nov 3; 5(6):522.
Doward LC, Ratcliffe J, McKenna SP, Meads DM, Langley PC. A comparison of conjoint analysis and time trade off elicited utilities for quality of life states associated with the treatment of genital herpes. Poster presented at the 2002 ISPOR 5th Annual European Congress; November 2002. [abstract] Value Health. 2002 Nov 3; 5(6):574. doi: 10.1016/S1098-3015(10)61510-0
Meads DM, Whalley D, Van t' Kooster GA. Review of QoL and HRQoL instruments available for measuring outcome in HIV/AIDS. Poster presented at the 2002 ISPOR 5th Annual European Congress; November 2002. Rotterdam, The Netherlands. [abstract] Value Health. 2002 Nov 3; 5(6):572.
Doward LC, McKenna SP, Meads DM, Ratcliffe J, Whalley D, Langley PC. Investigation into the feasibility of deriving relative and absolute utility from the recurrent genital herpes quality of life questionnaire (RGHQOL). Poster presented at the 2002 ISPOR 5th Annual European Congress; November 2002. Rotterdam, The Netherlands. [abstract] Value Health. 2002 Nov; 5(6):573-4.
Irish WD, Neighbors DM, Grogg A, Lopez R, Girts T, Degen K. Performing epidemiological studies in schizophrenia: a propensity score model to predict selection of atypical antipsychotic. Poster presented at the 2002 ISPOR 7th Annual International Meeting; May 2002. Arlington, VA. [abstract] Value Health. 2002 May; 5(1):216.
Neighbors D, Irish WD, Lopez R, Degen K, Swann A, Grogg A. Inpatient medication utilization and costs of risperidone, olanzapine, and quetiapine: a retrospective chart abstraction study. Poster presented at the 2002 ISPOR 7th Annual International Meeting; May 19, 2002. Arlington, VA. [abstract] Value Health. 2002 May; 5(3):234.
Santanello NC, Baker D, Cappelleri JC, Copley-Merriman K, DeMarinis R, Gagnon JP, Hsuan A, Jackson J, Mahmoud R, Miller D, Morgan M, Osterhaus J, Tilson H, Willke R. Regulatory issues for health-related quality of life—PhRMA Health Outcomes Committee Workshop, 1999. Value Health. 2002 Jan;5(1):14-25.
Beard SM, Gaffney L. Economic differentiation between PPIS in the treatment of reflux esophagitis related to GERD. Value Health. 2002;4(6):511-2.